Use of Triplex CMV Vaccine in CAR T Cell Therapy
US-2026053918-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Wang Xiuli patents
Wang Xiuli is listed as an inventor on 34 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Xiuli |
| Total patents | 34 |
| First publication | Oct 12, 2017 |
| Latest publication | Feb 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
CAR for Treatment of HIV Infection
US-2026048117-A1 · Feb 19, 2026 · US
BAFF-R/CD19 targeted chimeric antigen receptor-modified T cells and use thereof
US-12545714-B2 · Feb 10, 2026 · US
Bi-specific targeted chimeric antigen receptor t cells
US-2026015404-A1 · Jan 15, 2026 · US
CS1 targeted chimeric antigen receptor-modified T cells
US-12497440-B2 · Dec 16, 2025 · US
CAR for treatment of HIV infection
US-12496338-B2 · Dec 16, 2025 · US
Use of triplex CMV vaccine in CAR T cell therapy
US-12478672-B2 · Nov 25, 2025 · US
Compositions and uses of cd19 targeted chimeric antigen receptor modified immune cells
US-2025320291-A1 · Oct 16, 2025 · US
Cmv-hiv specific chimeric antigen receptor t cells
US-2025249102-A1 · Aug 7, 2025 · US
Methods for preparing cells for adoptive t cell therapy
US-2025171518-A1 · May 29, 2025 · US
Recent patents
Latest publications not already listed above.
Bispecific antibodies and uses thereof
US-2025074982-A1 · Mar 6, 2025 · US
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy
US-12161714-B2 · Dec 10, 2024 · US
Bi-specific targeted chimeric antigen receptor t cells
US-2024156928-A1 · May 16, 2024 · US
Chimeric antigen receptors and methods for reducing toxicity
US-2024148826-A1 · May 9, 2024 · US
Use of Triplex CMV Vaccine in CAR T Cell Therapy
US-2024016930-A1 · Jan 18, 2024 · US
Cs1 targeted chimeric antigen receptor-modified t cells
US-2024009288-A1 · Jan 11, 2024 · US
CS1 targeted chimeric antigen receptor-modified T cells for treatment of AL amyloidosis
US-11744862-B2 · Sep 5, 2023 · US
CS1 targeted chimeric antigen receptor-modified T cells
US-11730797-B2 · Aug 22, 2023 · US
Chimeric antigen receptors and methods for reducing toxicity
US-11701405-B2 · Jul 18, 2023 · US
CAR for Treatment of HIV Infection
US-2023070158-A1 · Mar 9, 2023 · US
Baff-r/cd19 targeted chimeric antigen receptor-modified t cells and use thereof
US-2022125840-A1 · Apr 28, 2022 · US
Bi-specific targeted chimeric antigen receptor t cells
US-2021386840-A1 · Dec 16, 2021 · US
Oxabicycloheptanes for enhancing car t cell function
US-2021379106-A1 · Dec 9, 2021 · US
Cs1 targeted chimeric antigen receptor-modified t cells
US-2021170001-A1 · Jun 10, 2021 · US
Methods for preparing cells for adoptive t cell therapy
US-2021102165-A1 · Apr 8, 2021 · US
Chimeric antigen receptors and methods for reducing toxicity
US-2021046155-A1 · Feb 18, 2021 · US
Treatment of cns lymphoma and systemic lymphoma with intracerebroventricularly administered cd19 car
US-2020345823-A1 · Nov 5, 2020 · US
CS1 targeted chimeric antigen receptor-modified T cells
US-10821161-B2 · Nov 3, 2020 · US
Cs1 targeted chimeric antigen receptor-modified t cells for treatment of al amyloidosis
US-2020188432-A1 · Jun 18, 2020 · US
Methods for preparing cells for adoptive t cell therapy
US-2018320133-A1 · Nov 8, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hope City | 32 |
| Baker Hughes Inc | 2 |
| Wang Xiuli | 1 |
| Forman Stephen J | 1 |
| Lixte Biotechnology Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K40/11 | 32 |
| A61K40/31 | 31 |
| C07K14/7051 | 26 |
| C07K2319/03 | 26 |
| C07K2317/622 | 26 |